Search Results

Oridonin 100 mg  | 99.04%

TargetMol

Oridonin is a diterpenoid isolated from Rabdosia rubescens with anti-tumor, anti-bacterial and anti-inflammatory effects. It acts as an inhibitor of AKT, with IC50s of 8.4 and 8.9 μM for AKT1 and AKT2.

More Information Supplier Page

Oridonin 10 mg  | 99.04%

TargetMol

Oridonin is a diterpenoid isolated from Rabdosia rubescens with anti-tumor, anti-bacterial and anti-inflammatory effects. It acts as an inhibitor of AKT, with IC50s of 8.4 and 8.9 μM for AKT1 and AKT2.

More Information Supplier Page

Oridonin 50 mg  | 99.04%

TargetMol

Oridonin is a diterpenoid isolated from Rabdosia rubescens with anti-tumor, anti-bacterial and anti-inflammatory effects. It acts as an inhibitor of AKT, with IC50s of 8.4 and 8.9 μM for AKT1 and AKT2.

More Information Supplier Page

KN-62 10 mg  | 98.77%

TargetMol

KN-62 is a potent and specific Ca2+/calmodulin-dependent protein kinase II (CaMKII) inhibitor with Ki of 0.9 μM.

More Information Supplier Page

Oritavancin diphosphate 5 mg  | 100.00%

TargetMol

Oritavancin diphosphate is a novel semisynthetic glycopeptide antibiotic which is being developed for the treatment of serious Gram-positive bacterial infections.

More Information Supplier Page

Oritavancin diphosphate 50 mg  | 100.00%

TargetMol

Oritavancin diphosphate is a novel semisynthetic glycopeptide antibiotic which is being developed for the treatment of serious Gram-positive bacterial infections.

More Information Supplier Page

Oritavancin diphosphate 2 mg  | 100.00%

TargetMol

Oritavancin diphosphate is a novel semisynthetic glycopeptide antibiotic which is being developed for the treatment of serious Gram-positive bacterial infections.

More Information Supplier Page

Oritavancin diphosphate 10 mg  | 100.00%

TargetMol

Oritavancin diphosphate is a novel semisynthetic glycopeptide antibiotic which is being developed for the treatment of serious Gram-positive bacterial infections.

More Information Supplier Page